The medical technology industry has enjoyed a period of exceptional performance over the last five years. Despite concerns about rising healthcare costs and the struggle for medtech companies to develop innovative new products and services, CEOs and investors remain optimistic about the prospects for the industry. In the attached paper, we will examine the factors driving the recent performance of the industry and how medtech can continue to drive value.
Principal, Deals, PwC US
Manager, US Deals, PwC US